Clinical Trial Participant Emergency Contact Form

Clinical trials demand rigorous safety protocols and immediate access to emergency contact information. This Clinical Trial Participant Emergency Contact Form is designed specifically for research institutions, pharmaceutical companies, contract research organizations (CROs), and healthcare facilities conducting clinical studies.

Why emergency preparedness matters in clinical trials

When participants experience adverse reactions or medical emergencies during a trial, every second counts. Having comprehensive, up-to-date emergency contact information ensures study coordinators can reach family members, primary care providers, and emergency services quickly. This form captures all critical details—from participant information and medical history to multiple emergency contacts and adverse reaction protocols—in one centralized, accessible location.

How this template supports your clinical research

This template collects essential participant demographics, primary and secondary emergency contacts, medical information relevant to emergency response, study coordinator details, and explicit consent for emergency contact procedures. It's designed to meet regulatory requirements while remaining straightforward for participants to complete during enrollment or screening visits.

Paperform makes it easy to customize this template with conditional logic—showing different fields based on trial phase or participant risk category—and seamlessly integrate with your research management systems via Stepper (stepper.io). You can automatically route completed forms to your clinical database, trigger notification workflows when information updates, and maintain audit trails for regulatory compliance.

Need participants to review and sign acknowledgment forms? Papersign (papersign.com) lets you turn emergency contact acknowledgments into legally binding eSignature documents, keeping everything linked to the original form submission for complete traceability.

Whether you're running Phase I safety trials or long-term observational studies, this template helps you maintain the highest standards of participant safety and regulatory compliance—without adding administrative burden to your study coordinators.